Works matching AU Giusti, Raffaele

Results: 43
    1
    2

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    3

    Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.

    Published in:
    2020
    By:
    • Cortellini, Alessio;
    • Friedlaender, Alex;
    • Banna, Giuseppe L.;
    • Porzio, Giampiero;
    • Bersanelli, Melissa;
    • Cappuzzo, Federico;
    • Aerts, Joachim G.J.V.;
    • Giusti, Raffaele;
    • Bria, Emilio;
    • Cortinovis, Diego;
    • Grossi, Francesco;
    • Migliorino, Maria R.;
    • Galetta, Domenico;
    • Passiglia, Francesco;
    • Berardi, Rossana;
    • Mazzoni, Francesca;
    • Di Noia, Vincenzo;
    • Signorelli, Diego;
    • Tuzi, Alessandro;
    • Gelibter, Alain
    Publication type:
    journal article
    4

    Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

    Published in:
    2019
    By:
    • Cortellini, Alessio;
    • Chiari, Rita;
    • Ricciuti, Biagio;
    • Metro, Giulio;
    • Perrone, Fabiana;
    • Tiseo, Marcello;
    • Bersanelli, Melissa;
    • Bordi, Paola;
    • Santini, Daniele;
    • Giusti, Raffaele;
    • Grassadonia, Antonino;
    • Di Marino, Pietro;
    • Tinari, Nicola;
    • De Tursi, Michele;
    • Zoratto, Federica;
    • Veltri, Enzo;
    • Malorgio, Francesco;
    • Garufi, Carlo;
    • Russano, Marco;
    • Anesi, Cecilia
    Publication type:
    journal article
    5
    6

    Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2209, doi. 10.1007/s00262-020-02613-9
    By:
    • Cortellini, Alessio;
    • Tiseo, Marcello;
    • Banna, Giuseppe L.;
    • Cappuzzo, Federico;
    • Aerts, Joachim G. J. V.;
    • Barbieri, Fausto;
    • Giusti, Raffaele;
    • Bria, Emilio;
    • Cortinovis, Diego;
    • Grossi, Francesco;
    • Migliorino, Maria R.;
    • Galetta, Domenico;
    • Passiglia, Francesco;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Morabito, Alessandro;
    • Genova, Carlo;
    • Mazzoni, Francesca;
    • Di Noia, Vincenzo;
    • Signorelli, Diego
    Publication type:
    Article
    7

    What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.

    Published in:
    Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1439, doi. 10.1177/1078155219843161
    By:
    • Cortellini, Alessio;
    • Porzio, Giampiero;
    • Cofini, Vincenza;
    • Necozione, Stefano;
    • Giusti, Raffaele;
    • Marchetti, Paolo;
    • Aloe Spiriti, Maria A;
    • Costanzi, Andrea;
    • Peris, Flaminia;
    • Ravoni, Giulio;
    • Spinelli, Giuseppe;
    • Ficorella, Corrado;
    • Verna, Lucilla
    Publication type:
    Article
    8
    9
    10
    11

    High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01226-2
    By:
    • Cortellini, Alessio;
    • Giusti, Raffaele;
    • Filetti, Marco;
    • Citarella, Fabrizio;
    • Adamo, Vincenzo;
    • Santini, Daniele;
    • Buti, Sebastiano;
    • Nigro, Olga;
    • Cantini, Luca;
    • Di Maio, Massimo;
    • Aerts, Joachim G. J. V.;
    • Bria, Emilio;
    • Bertolini, Federica;
    • Ferrara, Miriam Grazia;
    • Ghidini, Michele;
    • Grossi, Francesco;
    • Guida, Annalisa;
    • Berardi, Rossana;
    • Morabito, Alessandro;
    • Genova, Carlo
    Publication type:
    Article
    12
    13
    14

    Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 3955, doi. 10.3390/cancers16233955
    By:
    • Filetti, Marco;
    • Occhipinti, Mario;
    • Cirillo, Alessio;
    • Scirocchi, Fabio;
    • Ugolini, Alessio;
    • Giusti, Raffaele;
    • Lombardi, Pasquale;
    • Daniele, Gennaro;
    • Botticelli, Andrea;
    • Lo Russo, Giuseppe;
    • De Braud, Filippo;
    • Marchetti, Paolo;
    • Nuti, Marianna;
    • Ferretti, Elisabetta;
    • Farina, Lorenzo;
    • Rughetti, Aurelia;
    • Petti, Manuela
    Publication type:
    Article
    15

    Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival

    Published in:
    Cancers, 2023, v. 15, n. 20, p. 5052, doi. 10.3390/cancers15205052
    By:
    • Choucair, Khalil;
    • Nebhan, Caroline;
    • Cortellini, Alessio;
    • Hentzen, Stijn;
    • Wang, Yinghong;
    • Liu, Cynthia;
    • Giusti, Raffaele;
    • Filetti, Marco;
    • Ascierto, Paolo Antonio;
    • Vanella, Vito;
    • Galetta, Domenico;
    • Catino, Annamaria;
    • Al-Bzour, Nour;
    • Saeed, Azhar;
    • Cavalcante, Ludimila;
    • Pizzutilo, Pamela;
    • Genova, Carlo;
    • Bersanelli, Melissa;
    • Buti, Sebastiano;
    • Johnson, Douglas B.
    Publication type:
    Article
    16
    17

    PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.

    Published in:
    2021
    By:
    • Santini, Daniele;
    • Zeppola, Tea;
    • Russano, Marco;
    • Citarella, Fabrizio;
    • Anesi, Cecilia;
    • Buti, Sebastiano;
    • Tucci, Marco;
    • Russo, Alessandro;
    • Sergi, Maria Chiara;
    • Adamo, Vincenzo;
    • Stucci, Luigia S.;
    • Bersanelli, Melissa;
    • Mazzaschi, Giulia;
    • Spagnolo, Francesco;
    • Rastelli, Francesca;
    • Giorgi, Francesca Chiara;
    • Giusti, Raffaele;
    • Filetti, Marco;
    • Marchetti, Paolo;
    • Botticelli, Andrea
    Publication type:
    journal article
    18
    19
    20

    Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study.

    Published in:
    Oncologist, 2019, v. 24, n. 6, p. e327, doi. 10.1634/theoncologist.2018-0618
    By:
    • Cortellini, Alessio;
    • Buti, Sebastiano;
    • Santini, Daniele;
    • Perrone, Fabiana;
    • Giusti, Raffaele;
    • Tiseo, Marcello;
    • Bersanelli, Melissa;
    • Michiara, Maria;
    • Grassadonia, Antonino;
    • Brocco, Davide;
    • Tinari, Nicola;
    • De Tursi, Michele;
    • Zoratto, Federica;
    • Veltri, Enzo;
    • Marconcini, Riccardo;
    • Malorgio, Francesco;
    • Garufi, Carlo;
    • Russano, Marco;
    • Anesi, Cecilia;
    • Zeppola, Tea
    Publication type:
    Article
    21

    Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1.

    Published in:
    Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01243
    By:
    • Botticelli, Andrea;
    • Mezi, Silvia;
    • Pomati, Giulia;
    • Cerbelli, Bruna;
    • Cerbelli, Edoardo;
    • Roberto, Michela;
    • Giusti, Raffaele;
    • Cortellini, Alessio;
    • Lionetto, Luana;
    • Scagnoli, Simone;
    • Zizzari, Ilaria Grazia;
    • Nuti, Marianna;
    • Simmaco, Maurizio;
    • Marchetti, Paolo
    Publication type:
    Article
    22

    Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting.

    Published in:
    International Journal of Cancer, 2020, v. 146, n. 7, p. 1917, doi. 10.1002/ijc.32583
    By:
    • Pizzuti, Laura;
    • Krasniqi, Eriseld;
    • Barchiesi, Giacomo;
    • Della Giulia, Marina;
    • Izzo, Fiorentino;
    • Sanguineti, Giuseppe;
    • Marchetti, Paolo;
    • Mazzotta, Marco;
    • Giusti, Raffaele;
    • Botticelli, Andrea;
    • Gamucci, Teresa;
    • Natoli, Clara;
    • Grassadonia, Antonino;
    • Tinari, Nicola;
    • Iezzi, Laura;
    • Tomao, Silverio;
    • Tomao, Federica;
    • Tonini, Giuseppe;
    • Santini, Daniele;
    • Astone, Antonio
    Publication type:
    Article
    23
    24
    25
    26
    27

    Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 3, p. 483, doi. 10.1111/1759-7714.14256
    By:
    • Banna, Giuseppe L.;
    • Tiseo, Marcello;
    • Cortinovis, Diego L.;
    • Facchinetti, Francesco;
    • Aerts, Joachim G. J. V.;
    • Baldessari, Cinzia;
    • Giusti, Raffaele;
    • Bria, Emilio;
    • Grossi, Francesco;
    • Berardi, Rossana;
    • Morabito, Alessandro;
    • Catino, Annamaria;
    • Genova, Carlo;
    • Mazzoni, Francesca;
    • Gelibter, Alain;
    • Rastelli, Francesca;
    • Macerelli, Marianna;
    • Chiari, Rita;
    • Gori, Stefania;
    • Mansueto, Giovanni
    Publication type:
    Article
    28

    Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 6, p. 880, doi. 10.1111/1759-7714.13852
    By:
    • Cortellini, Alessio;
    • De Giglio, Andrea;
    • Cannita, Katia;
    • Cortinovis, Diego L.;
    • Cornelissen, Robin;
    • Baldessari, Cinzia;
    • Giusti, Raffaele;
    • D'Argento, Ettore;
    • Grossi, Francesco;
    • Santoni, Matteo;
    • Catino, Annamaria;
    • Berardi, Rossana;
    • Sforza, Vincenzo;
    • Rossi, Giovanni;
    • Antonuzzo, Lorenzo;
    • Di Noia, Vincenzo;
    • Signorelli, Diego;
    • Gelibter, Alain;
    • Occhipinti, Mario Alberto;
    • Follador, Alessandro
    Publication type:
    Article
    29
    30

    Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920968463
    By:
    • Bersanelli, Melissa;
    • Giannarelli, Diana;
    • De Giorgi, Ugo;
    • Pignata, Sandro;
    • Di Maio, Massimo;
    • Verzoni, Elena;
    • Clemente, Alberto;
    • Guadalupi, Valentina;
    • Signorelli, Diego;
    • Tiseo, Marcello;
    • Giusti, Raffaele;
    • Filetti, Marco;
    • Di Napoli, Marilena;
    • Calvetti, Lorenzo;
    • Cappetta, Alessandro;
    • Ermacora, Paola;
    • Zara, Diego;
    • Barbieri, Fausto;
    • Baldessari, Cinzia;
    • Scotti, Vieri
    Publication type:
    Article
    31
    32

    The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.

    Published in:
    Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203
    By:
    • Botticelli, Andrea;
    • Cirillo, Alessio;
    • Scagnoli, Simone;
    • Cerbelli, Bruna;
    • Strigari, Lidia;
    • Cortellini, Alessio;
    • Pizzuti, Laura;
    • Vici, Patrizia;
    • De Galitiis, Federica;
    • Di Pietro, Francesca Romana;
    • Cerbelli, Edoardo;
    • Ghidini, Michele;
    • D'Amati, Giulia;
    • Della Rocca, Carlo;
    • Mezi, Silvia;
    • Gelibter, Alain;
    • Giusti, Raffaele;
    • Cortesi, Enrico;
    • Ascierto, Paolo Antonio;
    • Nuti, Marianna
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40

    High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases.

    Published in:
    Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.588862
    By:
    • Laganà, Marta;
    • Gurizzan, Cristina;
    • Roca, Elisa;
    • Cortinovis, Diego;
    • Signorelli, Diego;
    • Pagani, Filippo;
    • Bettini, Anna;
    • Bonomi, Lucia;
    • Rinaldi, Silvia;
    • Berardi, Rossana;
    • Filetti, Marco;
    • Giusti, Raffaele;
    • Pilotto, Sara;
    • Milella, Michele;
    • Intagliata, Salvatore;
    • Baggi, Alice;
    • Cortellini, Alessio;
    • Soto Parra, Hector;
    • Brighenti, Matteo;
    • Petrelli, Fausto
    Publication type:
    Article
    41
    42
    43